Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane versus desflurane in middle ear surgery
ACTRN12624000610538Phase 4Completed
- Sponsor
- Harran University
- Start
- Apr 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sevoflurane and desflurane (2 arms), sponsored by Harran University. Primary endpoint: Metabolomic effects of inhalation anesthetics. Started Apr 2024; status: completed.
02
Drugs
sevofluranedesflurane
Beyond the preview
Go deeper on ACTRN12624000610538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000610538.